0 Évaluations
ID

20909

Description

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00426712

Lien

https://clinicaltrials.gov/show/NCT00426712

Mots-clés

Versions (1)
  1. 27/03/2017 27/03/2017 -
Téléchargé le

27 mars 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Hepatitis B NCT00426712

    Anglais

    Eligibility Hepatitis B NCT00426712

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    willing and able to give written informed consent
    Description

    Informed Consent

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430 (Informed Consent)
    progressive loss of kidney function with more advanced stage 3 (gfr at least 45 ml/min) or stage 4 chronic kidney disease by national kidney foundation classification, and are expected to eventually go on hemodialysis
    Description

    Renal function Loss Progressive | Chronic kidney disease Chronic kidney disease NKF classification | Hemodialysis Expected

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0232804 (Renal function)
    SNOMED
    11953005
    LOINC
    LP31398-8
    UMLS CUI [1,2]
    C1517945 (Loss)
    UMLS CUI [1,3]
    C0205329 (Progressive)
    SNOMED
    252157006
    LOINC
    LA25478-1
    UMLS CUI [2,1]
    C1561643 (Chronic Kidney Diseases)
    SNOMED
    709044004
    UMLS CUI [2,2]
    C2074730 (chronic kidney disease (NKF classification))
    UMLS CUI [3,1]
    C0019004 (Hemodialysis)
    SNOMED
    302497006
    LOINC
    LA9975-9
    UMLS CUI [3,2]
    C1517001 (Expected (qualifier))
    body mass index of 31 or less
    Description

    Body mass index

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1305855 (Body mass index)
    SNOMED
    60621009
    LOINC
    LP35925-4
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    received previous vaccination with any hbv vaccine (1 or more doses)
    Description

    Vaccination Hepatitis B Vaccine Dose Quantity

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0042196 (Vaccination)
    SNOMED
    33879002
    LOINC
    LP29692-8
    UMLS CUI [1,2]
    C2240392 (Hepatitis B Vaccines)
    SNOMED
    871822003
    UMLS CUI [1,3]
    C0178602 (Dosage)
    SNOMED
    260911001
    LOINC
    LP7180-5
    UMLS CUI [1,4]
    C1265611 (Quantity)
    SNOMED
    246205007
    LOINC
    LP202968-6
    any history of hbv infection
    Description

    Hepatitis B

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0019163 (Hepatitis B)
    SNOMED
    66071002
    LOINC
    LA18126-5
    pregnant or breast-feeding, or planning a pregnancy during the study
    Description

    Pregnancy | Breast Feeding | Pregnancy, Planned

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961 (Pregnancy)
    SNOMED
    289908002
    LOINC
    LP75920-6
    UMLS CUI [2]
    C0006147 (Breast Feeding)
    SNOMED
    169741004
    LOINC
    LP420040-0
    UMLS CUI [3]
    C0032992 (Pregnancy, Planned)
    SNOMED
    169565003
    has autoimmune disease
    Description

    Autoimmune Disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0004364 (Autoimmune Diseases)
    SNOMED
    85828009
    diagnosis of chronic kidney failure due to autoimmune disease
    Description

    Chronic Kidney Failure Due to Autoimmune Disease

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0022661 (Kidney Failure, Chronic)
    SNOMED
    46177005
    LOINC
    LP146090-8
    UMLS CUI [1,2]
    C0678226 (Due to)
    SNOMED
    42752001
    UMLS CUI [1,3]
    C0004364 (Autoimmune Diseases)
    SNOMED
    85828009
    receiving hemodialysis treatment at the time of enrollment
    Description

    Hemodialysis

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0019004 (Hemodialysis)
    SNOMED
    302497006
    LOINC
    LA9975-9
    received any blood products or antibodies within 3 months prior to study entry, or is likely to require blood products during the study
    Description

    Blood product | Antibodies

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0456388 (Blood product)
    SNOMED
    410652009
    LOINC
    LP32808-5
    UMLS CUI [2]
    C3495458 (antibodies (medication))
    ever received an injection with dna plasmids or oligonucleotides
    Description

    Plasmid DNA Injection | Oligonucleotides Injection

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0032136 (Plasmids)
    SNOMED
    373944006
    UMLS CUI [1,2]
    C1828121 (Injection Route of Drug Administration)
    UMLS CUI [2,1]
    C0028953 (Oligonucleotides)
    SNOMED
    23243007
    UMLS CUI [2,2]
    C1828121 (Injection Route of Drug Administration)
    received erythropoietin within 7 days prior to the first study injection
    Description

    Erythropoietin

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0014822 (Erythropoietin)
    SNOMED
    111167001
    LOINC
    LP15554-6
    received vaccination with any vaccines during the 4 weeks prior to study entry
    Description

    Vaccination Vaccine

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0042196 (Vaccination)
    SNOMED
    33879002
    LOINC
    LP29692-8
    UMLS CUI [1,2]
    C0042210 (Vaccines)
    SNOMED
    787859002
    LOINC
    LA20283-0
    received any other investigational medicinal agent during the 4 weeks prior to study entry
    Description

    Investigational New Drugs

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0013230 (Investigational New Drugs)
    Retour au début de la page

    Similar models

    Eligibility Hepatitis B NCT00426712

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Informed Consent
    Item
    willing and able to give written informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Renal function Loss Progressive | Chronic kidney disease Chronic kidney disease NKF classification | Hemodialysis Expected
    Item
    progressive loss of kidney function with more advanced stage 3 (gfr at least 45 ml/min) or stage 4 chronic kidney disease by national kidney foundation classification, and are expected to eventually go on hemodialysis
    boolean
    C0232804 (UMLS CUI [1,1])
    C1517945 (UMLS CUI [1,2])
    C0205329 (UMLS CUI [1,3])
    C1561643 (UMLS CUI [2,1])
    C2074730 (UMLS CUI [2,2])
    C0019004 (UMLS CUI [3,1])
    C1517001 (UMLS CUI [3,2])
    Body mass index
    Item
    body mass index of 31 or less
    boolean
    C1305855 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Vaccination Hepatitis B Vaccine Dose Quantity
    Item
    received previous vaccination with any hbv vaccine (1 or more doses)
    boolean
    C0042196 (UMLS CUI [1,1])
    C2240392 (UMLS CUI [1,2])
    C0178602 (UMLS CUI [1,3])
    C1265611 (UMLS CUI [1,4])
    Hepatitis B
    Item
    any history of hbv infection
    boolean
    C0019163 (UMLS CUI [1])
    Pregnancy | Breast Feeding | Pregnancy, Planned
    Item
    pregnant or breast-feeding, or planning a pregnancy during the study
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    C0032992 (UMLS CUI [3])
    Autoimmune Disease
    Item
    has autoimmune disease
    boolean
    C0004364 (UMLS CUI [1])
    Chronic Kidney Failure Due to Autoimmune Disease
    Item
    diagnosis of chronic kidney failure due to autoimmune disease
    boolean
    C0022661 (UMLS CUI [1,1])
    C0678226 (UMLS CUI [1,2])
    C0004364 (UMLS CUI [1,3])
    Hemodialysis
    Item
    receiving hemodialysis treatment at the time of enrollment
    boolean
    C0019004 (UMLS CUI [1])
    Blood product | Antibodies
    Item
    received any blood products or antibodies within 3 months prior to study entry, or is likely to require blood products during the study
    boolean
    C0456388 (UMLS CUI [1])
    C3495458 (UMLS CUI [2])
    Plasmid DNA Injection | Oligonucleotides Injection
    Item
    ever received an injection with dna plasmids or oligonucleotides
    boolean
    C0032136 (UMLS CUI [1,1])
    C1828121 (UMLS CUI [1,2])
    C0028953 (UMLS CUI [2,1])
    C1828121 (UMLS CUI [2,2])
    Erythropoietin
    Item
    received erythropoietin within 7 days prior to the first study injection
    boolean
    C0014822 (UMLS CUI [1])
    Vaccination Vaccine
    Item
    received vaccination with any vaccines during the 4 weeks prior to study entry
    boolean
    C0042196 (UMLS CUI [1,1])
    C0042210 (UMLS CUI [1,2])
    Investigational New Drugs
    Item
    received any other investigational medicinal agent during the 4 weeks prior to study entry
    boolean
    C0013230 (UMLS CUI [1])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial